RT Journal Article
T1 Outpatients' Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project
A1 Margusino-Framinan, Luis
A1 Fernandez-Llamazares, Cecilia M.
A1 Negro-Vega, Eva
A1 Tortajada-Goitia, Begona
A1 Lizeaga, Garbine
A1 Mercadal-Orfila, Gabriel
A1 Almeida-Gonzalez, Carmen
A1 Morillo-Verdugo, Ramon
K1 telepharmacy
K1 coronavirus
K1 pharmaceutical care
K1 hospital pharmacy service
K1 healthcare quality assessment
K1 patient reported experience measures
K1 Willingness-to-pay
K1 Adjusted life year
K1 Pharmaceutical care
K1 Pharmacy services
K1 Telemedicine
K1 Implementation
K1 Future
AB Background: Telepharmacy, as a remote pharmaceutical care procedure, is being used worldwide during the COVID-19 pandemic, with the aim of preserving the health of patients and professionals. Its future development should incorporate the assessment of patient perception, but no research study has investigated it.Objective: The objective was to poll the opinions and experiences of outpatients with telepharmacy through a purpose-developed questionnaire and to assess it's quality through an internal validity and reliability analysis.Methods: Cross-sectional observational study of adult patients who used telepharmacy services during the COVID-19 lockdown period in Spain. The subjects answered a 24-item questionnaire, after giving their informed consent. Place of delivery, informed pharmacotherapeutic follow-up, opinion about telepharmacy, future development, ethics/satisfaction, and coordination constituted the six questionnaire categories. After assessing the adequate sample size with the Kaiser-Meyer-Olkin test, the Bartlett sphericity test analyzed the validity of the questionnaire. The intraclass correlation coefficient and Cronbach's alpha coefficient calculations verified the reliability and internal consistency.Results: A total of 9442 interviews were administered to patients from 81 hospitals, of which 8079 were valid (52.8% female). A 54.1% were aged between 41-65 years; 42.7% had been in treatment for more than 5 years; 42.8% lived between 6-31 miles from the hospital. As many as 96.7% of patients were "satisfied" or "very satisfied" with telepharmacy, 97.5% considering it complementary to their usual follow-up; 55.9% expressed a preference for being followed up face to face when visiting the hospital. 75.6% said they had rather receive their medication at home. The sample size obtained was deemed appropriate [the Kaiser-Meyer-Olkin test (0.789) and Bartlett's sphericity test (p
PB Dove medical press ltd
SN 1178-2390
YR 2021
FD 2021-01-01
LK https://hdl.handle.net/10668/26777
UL https://hdl.handle.net/10668/26777
LA en
DS RISalud
RD Feb 23, 2025